Page 170 - இந்தியன் சபை ஆஃப் மருத்துவ ஆராய்ச்சி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Bharat Biotech s partner Ocugen seeks approval for Covaxin in Canada

Bharat Biotech s partner Ocugen seeks approval for Covaxin in Canada
orissapost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from orissapost.com Daily Mail and Mail on Sunday newspapers.

United statesAndhra pradeshShankar musunuriHealth interim order respecting the importationNational institute of virologyHealth canadaIndian council of medical researchOcugen incVaccigen ltdBharat biotechInterim order respectingChief executive officerIndian councilMedical researchNational instituteஒன்றுபட்டது மாநிலங்களில்

Karnataka to vaccinate school teachers on priority

Karnataka to vaccinate school teachers on priority
prokerala.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prokerala.com Daily Mail and Mail on Sunday newspapers.

Union health ministryIndian council of medical researchHealth ministerIndian councilMedical researchதொழிற்சங்கம் ஆரோக்கியம் அமைச்சகம்இந்தியன் சபை ஆஃப் மருத்துவ ஆராய்ச்சிஆரோக்கியம் அமைச்சர்இந்தியன் சபைமருத்துவ ஆராய்ச்சி

Follow the science | Media for Freedom

Shobha Shukla - CNS Covid-19 has posed innumerable health, economic, and social challenges for all, including people living with HIV. It has exposed the fragility of health systems around the globe and has diverted political attention and funding from other infectious diseases like TB and HIV. The opening session of the 11th International IAS Conference on HIV Science (#IAS2021) held virtually from Berlin, saw a lively panel discussing the tale of the two most horrendous recent pandemics in the history of our civilisation: Covid-19 and HIV/AIDS. Dr Anthony Fauci, Director of National Institute of Allergies and Infectious Diseases, USA, said that we cannot forget HIV just because we happen to be in the middle of Covid-19. Decades of investment and science in HIV research, albeit as yet unsuccessful in developing an HIV vaccine, has played a major role in the development of highly successful Covid-19 vaccines in a very short period of time. But the fact that we have a

South africaUnited statesAngela merkelSoumya swaminathanAnthony fauciShobha shuklaYvette raphaelJoe bidenJens spahnWorld health organizationMinistry of healthIndian council of medical researchDepartment of health researchNational institute of allergiesGermany healthNational institute for tuberculosis research

Wise to re-open primary schools first before secondary schools, says ICMR Chief

Highlights ICMR Chief on July 20 said that it would be wise to reopen primary schools first before secondary schools in India. Balram Bhargava said that antibody exposure is also similar in children as adults. He informed that some Scandinavian countries didn t shut their primary schools in any COVID-19 waves. New Delhi: As several states plan to reopen schools after the COVID-19 hiatus, the Indian Council of Medical Research (ICMR) Chief Balram Bhargava on Tuesday (July 20, 2021) said that it would be wise to reopen primary schools first before secondary schools in India. During a media briefing on the COVID-19 situation, Bhargava said, We know clearly that children can handle viral infections much better than adults. Antibody exposure is also similar in children as adults. Some Scandinavian countries didn t shut their primary schools in any coronavirus waves.

New delhiRound of national seroIndian council of medical researchIndian councilMedical researchChief balram bhargavaOnce indiaபுதியது டெல்ஹிஇந்தியன் சபை ஆஃப் மருத்துவ ஆராய்ச்சிஇந்தியன் சபைமருத்துவ ஆராய்ச்சிதலைமை பால்ராம் பார்கவாஒரு முறை இந்தியா

Covid: Two- third of Indians have virus antibodies, says Study

Two-thirds of India’s population, or over 900 million people, have antibodies to Covid-19, implying prior infections or possible protection, a nationwide survey has indicated, prompting some experts to predict that a third wave could be unlikely without fresh mutations in the virus. The survey has found that 67.6 per cent of a sample of 28,975 individuals aged six years or older from 70 districts across 21 states had antibodies against SARS-CoV-2, the virus that causes Covid-19, implying possible protection, either from prior infections or vaccination. Advertisement The findings suggest that the fraction of the country’s population possibly protected from Covid-19 infections has ballooned from 24.1 per cent in January 2021 to over 67.6 per cent by July 2021. But the results also imply that over 400 million of India’s 1.3 billion population are still vulnerable to the infection.

Tamil naduVinod paulT jacob johnBalram bhargavaNational institute of epidemiologyChristian medical collegeIndian council of medical researchIndian councilMedical researchதமிழ் நாடுவினோத் பால்டி ஜாகோப் ஜான்பால்ராம் பார்கவாதேசிய நிறுவனம் ஆஃப் தொற்றுநோய்கிறிஸ்துவர் மருத்துவ கல்லூரிஇந்தியன் சபை ஆஃப் மருத்துவ ஆராய்ச்சி